1. Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma
   Pedro Nicolau-Neto et al, 2020, Cancers CrossRef
2. Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach
   Zhiguang Xiao et al, 2019, Oncotarget CrossRef
3. CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells?
   Valentina Masciale et al, 2020, Oncotarget CrossRef
4. Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
   Lia Walcher et al, 2020, Front. Immunol. CrossRef
5. UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma
   Pei-Feng Liu et al, 2020, Diagnostics CrossRef
6. Cancer stem cells and macrophages: molecular connections and future perspectives against cancer
   Beatrice Aramini et al, 2021, Oncotarget CrossRef
7. Novel Primary Human Cancer Stem-Like Cell Populations from Non-Small Cell Lung Cancer: Inhibition of Cell Survival by Targeting NF-κB and MYC Signaling
   Beatrice A. Windmöller et al, 2021, Cells CrossRef
8. Elevated Expression of the RAGE Variant-V in SCLC Mitigates the Effect of Chemotherapeutic Drugs
   Bindhu K. Madhavan et al, 2021, Cancers CrossRef
9. Modulation of Immune Components on Stem Cell and Dormancy in Cancer
   Xiaofan Jiang et al, 2021, Cells CrossRef
10. Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight
    Lourdes Cortes-Dericks et al, 2022, Cancers CrossRef
11. EpCAM-positive disseminated cancer cells in bone marrow impact on survival of early-stage NSCLC patients
    Tobias Mederer et al, 2022, Lung Cancer CrossRef
12. Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments
    Beatrice Aramini et al, 2022, Cancers CrossRef
13. Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
    Yue Zheng et al, 2022, Front. Oncol. CrossRef
14. Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation
    K. Laxmi Swetha et al, 2022, Drug Deliv. and Transl. Res. CrossRef
15. Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates
    Maria José Costa et al, 2019, Sci Rep CrossRef
16. Properties of cancer stem cells
    Jacek Wojcierowski et al, 2022, Diagn Lab. CrossRef
17. Functional roles of microRnas in vasculogenic mimicry and resistance to therapy in human cancers: an update
    Alejandra Paola García-Hernández et al, 2024, Expert Review of Clinical Immunology CrossRef
18. Histological transformation in lung adenocarcinoma: Insights of mechanisms and therapeutic windows
    Nuopei Tan et al, 2024 CrossRef
19. Cancer Stem Cells in Lung Cancer, a Novel Frontier
    María Laura Barreiro Arcos et al, 2024 CrossRef